Literature DB >> 9094616

Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21.

A Morozov1, P Shiyanov, E Barr, J M Leiden, P Raychaudhuri.   

Abstract

The E7 oncoproteins encoded by the high-risk type of human papillomaviruses (HPVs) interact with the Rb family proteins Rb, p107, and p130. The Rb family proteins associate with the factors of the E2F family to form transcription repressor complexes, which control expression of several genes essential for S-phase entry and DNA replication. The E7 oncoproteins, by interacting with the Rb family proteins, dissociate the repressor complexes involving the factors of the E2F and Rb families, leading to a release of the E2F factors in their activator forms. In this study, we have addressed the mechanism by which the HPV type 16 (HPV16) E7 stimulates the cell cycle. Using a cell line that inducibly expresses the HPV16 E7 protein, we show that an accumulation of E7 induces quiescent cells to enter S phase and that this function of E7 depends on retention of the motif involved in binding to the Rb family proteins. To study the effects of E7 on normal human cells, we generated a recombinant adenovirus that expresses the HPV16 E7 protein. Infection of normal human fibroblasts, which were arrested in G1 phase by serum deprivation, with the E7-expressing virus induced the cells to enter S phase. The E7-induced S phase entry was accompanied by an increase in the activator form of E2F, but no increase in the cyclin-dependent kinase (cdk) activity was detected. Infection of serum-stimulated fibroblasts with a recombinant adenovirus expressing the cdk inhibitor p21 inhibited progression into S phase. Coinfection with the E7-expressing virus abrogated the p21 inhibition of progression into S phase without increasing the cdk activity. These results are consistent with the notion that E7 stimulates entry into S phase through targets downstream of the cdks such as the proteins of the E2F and Rb families.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094616      PMCID: PMC191491     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

2.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein.

Authors:  W C Phelps; K Münger; C L Yee; J A Barnes; P M Howley
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo.

Authors:  M C Blake; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

4.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  The retinoblastoma protein binds to a family of E2F transcription factors.

Authors:  J A Lees; M Saito; M Vidal; M Valentine; T Look; E Harlow; N Dyson; K Helin
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

7.  p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.

Authors:  P Shiyanov; S Bagchi; G Adami; J Kokontis; N Hay; M Arroyo; A Morozov; P Raychaudhuri
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

Review 8.  The biology of human papillomaviruses: from warts to cancer.

Authors:  L A Laimins
Journal:  Infect Agents Dis       Date:  1993-04

9.  Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.

Authors:  M Arroyo; S Bagchi; P Raychaudhuri
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

10.  HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.

Authors:  E W Lam; J D Morris; R Davies; T Crook; R J Watson; K H Vousden
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  18 in total

Review 1.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

2.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Authors:  K Smith-McCune; D Kalman; C Robbins; S Shivakumar; L Yuschenkoff; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16.

Authors:  A Schulze; B Mannhardt; K Zerfass-Thome; W Zwerschke; P Jansen-Dürr
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 5.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

6.  p27Kip1 induces an accumulation of the repressor complexes of E2F and inhibits expression of the E2F-regulated genes.

Authors:  P Shiyanov; S Hayes; N Chen; D G Pestov; L F Lau; P Raychaudhuri
Journal:  Mol Biol Cell       Date:  1997-09       Impact factor: 4.138

7.  Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein.

Authors:  Nicola Fiedler; Ellen Quant; Ludger Fink; Jianguang Sun; Ralph Schuster; Wolfram H Gerlich; Stephan Schaefer
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

8.  The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF).

Authors:  S E Seavey; M Holubar; L J Saucedo; M E Perry
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

9.  The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.

Authors:  Kwang-Jin Oh; Anna Kalinina; Jing Wang; Keiko Nakayama; Keiichi I Nakayama; Srilata Bagchi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  The human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints.

Authors:  Weifang Zhang; Jing Li; Sriramana Kanginakudru; Weiming Zhao; Xiuping Yu; Jason J Chen
Journal:  Virology       Date:  2009-11-27       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.